Extended Adjuvant Therapy for Breast Cancer—How Much Is Enough?
Jakesz et al have reported mature results of another extended adjuvant therapy trial, ABCSG Trial 6a, a randomized open-label trial that enrolled 856 postmenopausal women from ABCSG Trial 6. An editorial suggests that the ABCSG Trial 6a has some important limitations.
Gespeichert in:
| Veröffentlicht in: | JNCI : Journal of the National Cancer Institute 2007-12, Vol.99 (24), p.1825-1827 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1827 |
|---|---|
| container_issue | 24 |
| container_start_page | 1825 |
| container_title | JNCI : Journal of the National Cancer Institute |
| container_volume | 99 |
| creator | Prowell, Tatiana M. Stearns, Vered |
| description | Jakesz et al have reported mature results of another extended adjuvant therapy trial, ABCSG Trial 6a, a randomized open-label trial that enrolled 856 postmenopausal women from ABCSG Trial 6. An editorial suggests that the ABCSG Trial 6a has some important limitations. |
| doi_str_mv | 10.1093/jnci/djm264 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_221022386</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/jnci/djm264</oup_id><sourcerecordid>1479236751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c378t-34b1dbc9bb28238751c63a55e053e32631270b1cafae1f447ba63c88066d5b283</originalsourceid><addsrcrecordid>eNqFkLtOwzAUQC0EoqUwsSOLgQWF-hE_OqFSlbZSEUupEIvlOA5toEmwE2g3PoIv5EtIlQpGvNzl3HPlA8ApRlcY9Wg3zcyyG6crwsM90MYhRwHBiO2DNkJEBFKKsAWOvE9R_XokPAQtLJGgVJA26A_Xpc1iG8N-nFbvOivhbGGdLjYwyR28cVb7Eg50Zqz7_vwa5x_wrjILOPFwmOXV8-L6GBwk-tXbk93sgIfb4WwwDqb3o8mgPw0MFbIMaBjhODK9KCKSUCkYNpxqxixi1FLCKSYCRdjoRFuchKGINKdGSsR5zOod2gHnjbdw-VtlfanSvHJZfVKR-r-klvIaumwg43LvnU1U4ZYr7TYKI7Wtpba1VFOrps92yipa2fiP3eWpgYsGyKviH1PQgEtf2vUvqt2L4oIKpsaPT2pEJZ7POVNT-gOhhoE5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221022386</pqid></control><display><type>article</type><title>Extended Adjuvant Therapy for Breast Cancer—How Much Is Enough?</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Prowell, Tatiana M. ; Stearns, Vered</creator><creatorcontrib>Prowell, Tatiana M. ; Stearns, Vered</creatorcontrib><description>Jakesz et al have reported mature results of another extended adjuvant therapy trial, ABCSG Trial 6a, a randomized open-label trial that enrolled 856 postmenopausal women from ABCSG Trial 6. An editorial suggests that the ABCSG Trial 6a has some important limitations.</description><identifier>ISSN: 0027-8874</identifier><identifier>EISSN: 1460-2105</identifier><identifier>DOI: 10.1093/jnci/djm264</identifier><identifier>PMID: 18073372</identifier><identifier>CODEN: JNCIEQ</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Aminoglutethimide - therapeutic use ; Antineoplastic Agents, Hormonal - adverse effects ; Antineoplastic Agents, Hormonal - therapeutic use ; Aromatase Inhibitors - adverse effects ; Aromatase Inhibitors - therapeutic use ; Austria ; Breast cancer ; Breast Neoplasms - drug therapy ; Breast Neoplasms - prevention & control ; Chemotherapy, Adjuvant ; Clinical trials ; Disease-Free Survival ; Drug therapy ; Female ; Humans ; Nitriles - adverse effects ; Nitriles - therapeutic use ; Oncology ; Postmenopause ; Randomized Controlled Trials as Topic ; Tamoxifen - therapeutic use ; Treatment Outcome ; Triazoles - adverse effects ; Triazoles - therapeutic use</subject><ispartof>JNCI : Journal of the National Cancer Institute, 2007-12, Vol.99 (24), p.1825-1827</ispartof><rights>The Author 2007. Published by Oxford University Press. 2007</rights><rights>The Author 2007. Published by Oxford University Press.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c378t-34b1dbc9bb28238751c63a55e053e32631270b1cafae1f447ba63c88066d5b283</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1584,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18073372$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Prowell, Tatiana M.</creatorcontrib><creatorcontrib>Stearns, Vered</creatorcontrib><title>Extended Adjuvant Therapy for Breast Cancer—How Much Is Enough?</title><title>JNCI : Journal of the National Cancer Institute</title><addtitle>J Natl Cancer Inst</addtitle><description>Jakesz et al have reported mature results of another extended adjuvant therapy trial, ABCSG Trial 6a, a randomized open-label trial that enrolled 856 postmenopausal women from ABCSG Trial 6. An editorial suggests that the ABCSG Trial 6a has some important limitations.</description><subject>Aminoglutethimide - therapeutic use</subject><subject>Antineoplastic Agents, Hormonal - adverse effects</subject><subject>Antineoplastic Agents, Hormonal - therapeutic use</subject><subject>Aromatase Inhibitors - adverse effects</subject><subject>Aromatase Inhibitors - therapeutic use</subject><subject>Austria</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Breast Neoplasms - prevention & control</subject><subject>Chemotherapy, Adjuvant</subject><subject>Clinical trials</subject><subject>Disease-Free Survival</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Nitriles - adverse effects</subject><subject>Nitriles - therapeutic use</subject><subject>Oncology</subject><subject>Postmenopause</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Tamoxifen - therapeutic use</subject><subject>Treatment Outcome</subject><subject>Triazoles - adverse effects</subject><subject>Triazoles - therapeutic use</subject><issn>0027-8874</issn><issn>1460-2105</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkLtOwzAUQC0EoqUwsSOLgQWF-hE_OqFSlbZSEUupEIvlOA5toEmwE2g3PoIv5EtIlQpGvNzl3HPlA8ApRlcY9Wg3zcyyG6crwsM90MYhRwHBiO2DNkJEBFKKsAWOvE9R_XokPAQtLJGgVJA26A_Xpc1iG8N-nFbvOivhbGGdLjYwyR28cVb7Eg50Zqz7_vwa5x_wrjILOPFwmOXV8-L6GBwk-tXbk93sgIfb4WwwDqb3o8mgPw0MFbIMaBjhODK9KCKSUCkYNpxqxixi1FLCKSYCRdjoRFuchKGINKdGSsR5zOod2gHnjbdw-VtlfanSvHJZfVKR-r-klvIaumwg43LvnU1U4ZYr7TYKI7Wtpba1VFOrps92yipa2fiP3eWpgYsGyKviH1PQgEtf2vUvqt2L4oIKpsaPT2pEJZ7POVNT-gOhhoE5</recordid><startdate>20071219</startdate><enddate>20071219</enddate><creator>Prowell, Tatiana M.</creator><creator>Stearns, Vered</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20071219</creationdate><title>Extended Adjuvant Therapy for Breast Cancer—How Much Is Enough?</title><author>Prowell, Tatiana M. ; Stearns, Vered</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c378t-34b1dbc9bb28238751c63a55e053e32631270b1cafae1f447ba63c88066d5b283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aminoglutethimide - therapeutic use</topic><topic>Antineoplastic Agents, Hormonal - adverse effects</topic><topic>Antineoplastic Agents, Hormonal - therapeutic use</topic><topic>Aromatase Inhibitors - adverse effects</topic><topic>Aromatase Inhibitors - therapeutic use</topic><topic>Austria</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Breast Neoplasms - prevention & control</topic><topic>Chemotherapy, Adjuvant</topic><topic>Clinical trials</topic><topic>Disease-Free Survival</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Nitriles - adverse effects</topic><topic>Nitriles - therapeutic use</topic><topic>Oncology</topic><topic>Postmenopause</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Tamoxifen - therapeutic use</topic><topic>Treatment Outcome</topic><topic>Triazoles - adverse effects</topic><topic>Triazoles - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Prowell, Tatiana M.</creatorcontrib><creatorcontrib>Stearns, Vered</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>JNCI : Journal of the National Cancer Institute</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Prowell, Tatiana M.</au><au>Stearns, Vered</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extended Adjuvant Therapy for Breast Cancer—How Much Is Enough?</atitle><jtitle>JNCI : Journal of the National Cancer Institute</jtitle><addtitle>J Natl Cancer Inst</addtitle><date>2007-12-19</date><risdate>2007</risdate><volume>99</volume><issue>24</issue><spage>1825</spage><epage>1827</epage><pages>1825-1827</pages><issn>0027-8874</issn><eissn>1460-2105</eissn><coden>JNCIEQ</coden><abstract>Jakesz et al have reported mature results of another extended adjuvant therapy trial, ABCSG Trial 6a, a randomized open-label trial that enrolled 856 postmenopausal women from ABCSG Trial 6. An editorial suggests that the ABCSG Trial 6a has some important limitations.</abstract><cop>United States</cop><pub>Oxford University Press</pub><pmid>18073372</pmid><doi>10.1093/jnci/djm264</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0027-8874 |
| ispartof | JNCI : Journal of the National Cancer Institute, 2007-12, Vol.99 (24), p.1825-1827 |
| issn | 0027-8874 1460-2105 |
| language | eng |
| recordid | cdi_proquest_journals_221022386 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current) |
| subjects | Aminoglutethimide - therapeutic use Antineoplastic Agents, Hormonal - adverse effects Antineoplastic Agents, Hormonal - therapeutic use Aromatase Inhibitors - adverse effects Aromatase Inhibitors - therapeutic use Austria Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - prevention & control Chemotherapy, Adjuvant Clinical trials Disease-Free Survival Drug therapy Female Humans Nitriles - adverse effects Nitriles - therapeutic use Oncology Postmenopause Randomized Controlled Trials as Topic Tamoxifen - therapeutic use Treatment Outcome Triazoles - adverse effects Triazoles - therapeutic use |
| title | Extended Adjuvant Therapy for Breast Cancer—How Much Is Enough? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A57%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extended%20Adjuvant%20Therapy%20for%20Breast%20Cancer%E2%80%94How%20Much%20Is%20Enough?&rft.jtitle=JNCI%20:%20Journal%20of%20the%20National%20Cancer%20Institute&rft.au=Prowell,%20Tatiana%20M.&rft.date=2007-12-19&rft.volume=99&rft.issue=24&rft.spage=1825&rft.epage=1827&rft.pages=1825-1827&rft.issn=0027-8874&rft.eissn=1460-2105&rft.coden=JNCIEQ&rft_id=info:doi/10.1093/jnci/djm264&rft_dat=%3Cproquest_cross%3E1479236751%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=221022386&rft_id=info:pmid/18073372&rft_oup_id=10.1093/jnci/djm264&rfr_iscdi=true |